{
  "1": [
    [
      ""
    ]
  ],
  "2": [
    [
      ""
    ]
  ],
  "ipo_details": [
    [
      "IPO Date",
      "July 14, 2025 to July 16, 2025"
    ],
    [
      "Listing Date",
      "July 21, 2025"
    ],
    [
      "Face Value",
      "₹2per share"
    ],
    [
      "Issue Price",
      "₹570 per share"
    ],
    [
      "Lot Size",
      "26 Shares"
    ],
    [
      "Sale Type",
      "Offer For Sale"
    ],
    [
      "Total Issue Size",
      "5,95,75,319shares(aggregating up to ₹3,395.79Cr)"
    ],
    [
      "Employee Discount",
      "₹50.00"
    ],
    [
      "Issue Type",
      "BookbuildingIPO"
    ],
    [
      "Listing At",
      "BSE, NSE"
    ],
    [
      "Share Holding Pre Issue",
      "56,16,10,051shares"
    ],
    [
      "Share Holding Post Issue",
      "56,16,10,051shares"
    ]
  ],
  "reservation": [
    {
      "Investor Category": "QIB Shares Offered",
      "Shares Offered": "2,97,08,332 (49.87%)",
      "Maximum Allottees": "NA"
    },
    {
      "Investor Category": "− Anchor Investor Shares Offered",
      "Shares Offered": "1,78,24,999 (29.92%)",
      "Maximum Allottees": "NA"
    },
    {
      "Investor Category": "− QIB (Ex. Anchor) Shares Offered",
      "Shares Offered": "1,18,83,333 (19.95%)",
      "Maximum Allottees": "NA"
    },
    {
      "Investor Category": "NII (HNI) Shares Offered",
      "Shares Offered": "89,12,500 (14.96%)",
      "Maximum Allottees": "NA"
    },
    {
      "Investor Category": "− bNII > ₹10L",
      "Shares Offered": "59,41,667 (9.97%)",
      "Maximum Allottees": "16,323"
    },
    {
      "Investor Category": "− sNII < ₹10L",
      "Shares Offered": "29,70,833 (4.99%)",
      "Maximum Allottees": "8,161"
    },
    {
      "Investor Category": "Retail Shares Offered",
      "Shares Offered": "2,07,95,834 (34.91%)",
      "Maximum Allottees": "7,99,839"
    },
    {
      "Investor Category": "Employee Shares Offered",
      "Shares Offered": "1,58,653 (0.27%)",
      "Maximum Allottees": "NA"
    },
    {
      "Investor Category": "Total Shares Offered",
      "Shares Offered": "5,95,75,319 (100.00%)",
      "Maximum Allottees": ""
    }
  ],
  "5": [
    {
      "Application Category": "Only RII",
      "Maximum Bidding Limits": "Up to Rs 2 Lakhs",
      "Bidding at Cut-off Price Allowed": "Yes"
    },
    {
      "Application Category": "Only sNII",
      "Maximum Bidding Limits": "Rs 2 Lakhs to Rs 10 Lakhs",
      "Bidding at Cut-off Price Allowed": "No"
    },
    {
      "Application Category": "Only bNII",
      "Maximum Bidding Limits": "Rs 10 Lakhs to NII Reservation Portion",
      "Bidding at Cut-off Price Allowed": "No"
    },
    {
      "Application Category": "Only employee",
      "Maximum Bidding Limits": "",
      "Bidding at Cut-off Price Allowed": "Yes"
    },
    {
      "Application Category": "Employee + RII/NII",
      "Maximum Bidding Limits": "Employee limit:  (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)If applying as RII: Upto Rs. 2 lakhsIf applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs",
      "Bidding at Cut-off Price Allowed": "Yes for Employee and RII/NII"
    }
  ],
  "anchor_investors": [
    [
      "Bid Date",
      "July 11, 2025"
    ],
    [
      "Shares Offered",
      "1,78,24,999"
    ],
    [
      "Anchor Portion Size (In Cr.)",
      "1,016.02"
    ],
    [
      "Anchorlock-in periodend date for 50% shares (30 Days)",
      "August 15, 2025"
    ],
    [
      "Anchor lock-in period end date for remaining shares (90 Days)",
      "October 14, 2025"
    ]
  ],
  "timeline": [
    [
      "IPO Open Date",
      "Mon, Jul 14, 2025"
    ],
    [
      "IPO Close Date",
      "Wed, Jul 16, 2025"
    ],
    [
      "Tentative Allotment",
      "Thu, Jul 17, 2025"
    ],
    [
      "Initiation of Refunds",
      "Fri, Jul 18, 2025"
    ],
    [
      "Credit of Shares to Demat",
      "Fri, Jul 18, 2025"
    ],
    [
      "Tentative Listing Date",
      "Mon, Jul 21, 2025"
    ],
    [
      "Cut-off time for UPI mandate confirmation",
      "5 PM onJuly 16, 2025"
    ]
  ],
  "lots": [
    {
      "Application": "Retail (Min)",
      "Lots": "1",
      "Shares": "26",
      "Amount": "₹14,820"
    },
    {
      "Application": "Retail (Max)",
      "Lots": "13",
      "Shares": "338",
      "Amount": "₹1,92,660"
    },
    {
      "Application": "S-HNI (Min)",
      "Lots": "14",
      "Shares": "364",
      "Amount": "₹2,07,480"
    },
    {
      "Application": "S-HNI (Max)",
      "Lots": "67",
      "Shares": "1,742",
      "Amount": "₹9,92,940"
    },
    {
      "Application": "B-HNI (Min)",
      "Lots": "68",
      "Shares": "1,768",
      "Amount": "₹10,07,760"
    }
  ],
  "promoters_holdings": [
    [
      "Share Holding Pre Issue",
      "76.87%"
    ],
    [
      "Share Holding Post Issue",
      "74.68%"
    ]
  ],
  "company_financials": [
    [
      "Period Ended",
      "31 Mar 2025",
      "31 Mar 2024",
      "31 Mar 2023"
    ],
    [
      "Assets",
      "2,807.58",
      "2,398.11",
      "2,014.46"
    ],
    [
      "Total Income",
      "1,930.29",
      "1,483.07",
      "1,133.99"
    ],
    [
      "Profit After Tax",
      "451.26",
      "367.31",
      "385.19"
    ],
    [
      "EBITDA",
      "683.78",
      "519.96",
      "446.05"
    ],
    [
      "Net Worth",
      "2,409.86",
      "1,924.66",
      "1,740.67"
    ],
    [
      "Reserves and Surplus",
      "2,298.05",
      "1,815.39",
      "1,628.88"
    ],
    [
      "Total Borrowing",
      "108.95",
      "232.53",
      "125.06"
    ],
    [
      "Amount in ₹ Crore"
    ]
  ],
  "KPI": [
    {
      "KPI": "ROE",
      "Values": "20.82%"
    },
    {
      "KPI": "ROCE",
      "Values": "26.88%"
    },
    {
      "KPI": "Debt/Equity",
      "Values": "0.05"
    },
    {
      "KPI": "RoNW",
      "Values": "20.82%"
    },
    {
      "KPI": "PAT Margin",
      "Values": "23.38%"
    },
    {
      "KPI": "EBITDA Margin",
      "Values": "36.81%"
    },
    {
      "KPI": "Price to Book Value",
      "Values": "13.23"
    }
  ],
  "EPS": [
    {
      "": "EPS (Rs)",
      "Pre IPO": "8.07",
      "Post IPO": "8.07"
    },
    {
      "": "P/E (x)",
      "Pre IPO": "70.62",
      "Post IPO": "70.62"
    }
  ],
  "objectives": [
    {
      "S.No.": "1",
      "Objects of the Issue": "To achieve the benefits of listing the Equity Shares on the Stock Exchanges",
      "Expected Amount(₹ in crores)": ""
    }
  ],
  "listing_details": [
    [
      "Listing Date",
      "July 21, 2025"
    ],
    [
      "BSE Script Code",
      "544449"
    ],
    [
      "NSE Symbol",
      "ANTHEM"
    ],
    [
      "ISIN",
      "INE0CZ201020"
    ],
    [
      "Final Issue Price",
      "₹570 per share"
    ],
    [
      "NSE Listing Group",
      "EQ"
    ],
    [
      "BSE Listing Group",
      "B"
    ]
  ],
  "listing_day_trading": [
    {
      "Price Details": "Final Issue Price",
      "BSE": "₹570.00",
      "NSE": "₹570.00"
    },
    {
      "Price Details": "Open",
      "BSE": "₹723.10",
      "NSE": "₹723.05"
    },
    {
      "Price Details": "Low",
      "BSE": "₹723.05",
      "NSE": "₹723.05"
    },
    {
      "Price Details": "High",
      "BSE": "₹746.70",
      "NSE": "₹747.00"
    },
    {
      "Price Details": "Last Trade",
      "BSE": "₹730.35",
      "NSE": "₹730.35"
    }
  ],
  "review": [
    {
      "Review By": "Brokers",
      "Subscribe": "12",
      "Neutral": "1",
      "Avoid": "0"
    },
    {
      "Review By": "Members",
      "Subscribe": "8",
      "Neutral": "0",
      "Avoid": "0"
    }
  ],
  "bidding_details": [
    {
      "Category": "QIB",
      "Subscription (times)": "192.80",
      "Shares Offered": "1,18,83,334",
      "Shares bid for": "2,29,10,95,976"
    },
    {
      "Category": "NII",
      "Subscription (times)": "44.70",
      "Shares Offered": "89,12,500",
      "Shares bid for": "39,84,26,912"
    },
    {
      "Category": "bNII (bids above ₹10L)",
      "Subscription (times)": "51.66",
      "Shares Offered": "59,41,667",
      "Shares bid for": "30,69,18,534"
    },
    {
      "Category": "sNII (bids below ₹10L)",
      "Subscription (times)": "30.80",
      "Shares Offered": "29,70,833",
      "Shares bid for": "9,15,08,378"
    },
    {
      "Category": "Retail",
      "Subscription (times)": "5.98",
      "Shares Offered": "2,07,95,833",
      "Shares bid for": "12,42,99,214"
    },
    {
      "Category": "Employee",
      "Subscription (times)": "6.99",
      "Shares Offered": "1,58,654",
      "Shares bid for": "11,08,692"
    },
    {
      "Category": "Total",
      "Subscription (times)": "67.42",
      "Shares Offered": "4,17,50,321",
      "Shares bid for": "2,81,49,30,794"
    }
  ],
  "prospectus_links": [
    {
      "title": "Anthem Biosciences IPO DRHP",
      "href": "https://www.sebi.gov.in/filings/public-issues/jan-2025/anthem-biosciences-limited_90546.html",
      "text": "Anthem Biosciences IPODRHP"
    },
    {
      "title": "Anthem Biosciences IPO RHP",
      "href": "https://www.sebi.gov.in/filings/public-issues/jul-2025/anthem-biosciences-limited-rhp_95139.html",
      "text": "Anthem Biosciences IPORHP"
    },
    {
      "title": "Anthem Biosciences IPO Final Prospectus",
      "href": "https://www.sebi.gov.in/filings/public-issues/jul-2025/anthem-biosciences-limited-prospectus_95393.html",
      "text": "Anthem Biosciences IPOFinal Prospectus"
    }
  ],
  "promoters": "The promoters of the company are Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa and Ishaan Bhardwaj.",
  "company_contact_details": {
    "company_name": "Anthem Biosciences Ltd.",
    "address": "No. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area, Phase 1,, Bommasandra,, Bengaluru, ,, Karnataka, , 560099, Phone, :, Email, :, Website, :",
    "phone": "+91 080 6672 400",
    "email": "investors.abl@anthembio.com",
    "website": "https://www.anthembio.com/"
  },
  "ipo_registrar_details": {
    "name": "Kfin Technologies Ltd.",
    "phone": "04067162222",
    "email": "anthem.ipo@kfintech.com",
    "website": "https://ipostatus.kfintech.com/"
  },
  "about_company": {
    "description": "Incorporated in 2006, Anthem Biosciences Limited is an innovation-driven and technology-focused Contract Research, Development, and Manufacturing Organization (“CRDMO”) with fully integrated operations encompassing drug discovery, development, and manufacturing processes. The company serves diverse customers, including innovative, emerging biotech firms and large pharmaceutical companies on a global scale. The company manufactures specialized fermentation-based APIs, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. For the six months concluding on September 30, 2024, the company engaged in the manufacture of active pharmaceutical ingredients (API) and intermediates for ten commercial molecules, all of which have been supported since their discovery. As of September 30 2024, the company had 196 projects: 170 discovery projects (284 synthesized molecules), 132 early phase projects, 16 late phase projects (10 late phase molecules), and 13 commercial manufacturing projects (API and intermediates for 10 commercialized molecules). As of September 30 and March 31, 2024, the company had over 425 and 550 customers in our CRDMO and specialty ingredients businesses, spanning more than 44 countries, including the U.S., Europe, and Japan. As of March 31, 2024, the company served over 150 customers, from small biotech to large pharmaceutical companies. As of September 30, 2024, the company holds one patent in India, seven overseas, and has 24 pending global patent applications, including process patents for glycolipid synthesis and GLP-1 analogues. As of September 30 2024, the company's team consists of 600 employees, including medicinal chemists, microbiologists, molecular biologists, biochemists, experts in various in-vivo non-clinical research and chemical engineers. Competitive Strength",
    "competitive_strengths": []
  },
  "ipo_lead_managers": [
    {
      "name": "JM Financial Ltd.",
      "profile_link": "/report/ipo-lead-manager-review/112/18/",
      "title": "About JM Financial Ltd."
    },
    {
      "name": "Citigroup Global Markets India Pvt.Ltd.",
      "profile_link": "/report/ipo-lead-manager-review/112/23/",
      "title": "About Citigroup Global Markets India Pvt.Ltd."
    },
    {
      "name": "JP Morgan India Pvt.Ltd.",
      "profile_link": "/report/ipo-lead-manager-review/112/19/",
      "title": "About JP Morgan India Pvt.Ltd."
    },
    {
      "name": "Nomura Financial Advisory & Securities (India) Pvt.Ltd.",
      "profile_link": "/report/ipo-lead-manager-review/112/72/",
      "title": "About Nomura Financial Advisory & Securities (India) Pvt.Ltd."
    }
  ],
  "listing_gain_percent": "26.85%"
}